A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patients

Disease Markers

Volumn 31, Issue 5, 2011, Pages 303-309

  Chew, Constance S N ^a   Cherry, Catherine L ^b,c,d   Kamarulzaman, Adeeba ^e,f   Yien, Tan Hong ^e,f   Aghafar, Zayd ^a   Price, Patricia ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b BURNET INSTITUTE   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF MALAYA   (Malaysia)

^f UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

CCL5; CXCL10; HIV sensory neuropathy; Immune Reconstitution Disease; nucleoside analogue reverse transcriptase inhibitor sensory neuropathy

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE; FLUORESCENT DYE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALAYSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING; SENSORY NEUROPATHY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

EID: 80955139710     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0844     Document Type: Article

References (36)

1. C.L. Cherry et al., Nucleoside analogues and neuropathy in the era of HAART, J Clin Virol 26(2) (2003), 195-207. (Pubitemid 36206604)
2. M.A. French, P. Price and S.F. Stone, Immune restoration disease after antiretroviral therapy, AIDS 18(12) (2004), 1615-1627. (Pubitemid 39095778)
3. P. Price et al., Immune restoration diseases reflect diverse immunopathological mechanisms, Clin Microbiol Rev 22(4) (2009), 651-663.
4. N. Uceyler et al., Differential expression of cytokines in painful and painless neuropathies, Neurology 69(1) (2007), 42-49. (Pubitemid 47025203)
5. L.Kestens, N. Seddiki and P.R. Bohjanen, Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy, Curr Opin HIV AIDS 3(4) (2008), 419-424.
6. P. Aukrust, F. Muller and S.S. Froland, Circulating levels of RANTES in human immunodeficiency virus type 1 infection: Effect of potent antiretroviral therapy, J Infect Dis 177(4) (1998), 1091-1096. (Pubitemid 28155170)
7. L.R. Bisset et al., Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES,monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficientHIV-infected individuals with indinavir, AIDS 11(4) (1997), 485-491. (Pubitemid 27113010)
8. S. Fransen et al., RANTES production by T cells and CD8- mediated inhibition of human immunodeficiency virus geneexpression before initiation of potent antiretroviral therapy predict sustained suppression of viral replication, J Infect Dis 181(2) (2000), 505-512. (Pubitemid 30131817)
9. B.G.E. Oliver, J.H. Price, P. Phillips, M. Saphonn and V. Chhi Vun, Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning ART, J Infect Dis 202(11) (2010), 1728-1737.
10. K.I. Relucio et al., Proteomic analysis of serum cytokine levels in response to highly active antiretroviral therapy (HAART), J Proteome Res 4(2) (2005), 227-231. (Pubitemid 40548126)
11. E. Stylianou et al., Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-Alpha in HIV infection, Clin Exp Immunol 119(3) (2000), 479-485. (Pubitemid 30146344)
12. S.F. Stone, P. Price and M.A. French, Immune restoration disease: A consequence of dysregulated immune responses after HAART, Curr HIV Res 2(3) (2004), 235-242. (Pubitemid 38854936)
13. M. Crane et al., Immunopathogenesis of hepatic flare in HIV/ hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-Active antiretroviral therapy, J Infect Dis 199(7) (2009), 974-981.
14. S.C.Keswani et al., HIV-Associated sensory neuropathies, Aids 16(16) (2002), 2105-2117. (Pubitemid 35387264)
15. Y.T. So et al., Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey, Arch Neurol 45(9) (1988), 945-948.
16. I. Nagano et al., Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome, J Neurol Sci 136(1-2) (1996), 117-128. (Pubitemid 26100249)
17. S.L. Wesselingh et al., Cytokine dysregulation in HIV-Associated neurological disease, Adv Neuroimmunol 4(3) (1994), 199-206. (Pubitemid 24325865)
18. C.L. Cherry et al., Cytokine genotype suggests a role for inflammation in nucleoside analog-Associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk, AIDS Res Hum Retroviruses 24(2) (2008), 117-123. (Pubitemid 351282105)
19. C.L. Cherry et al., Evaluation of a clinical screening tool for HIV-Associated sensory neuropathies, Neurology 65(11) (2005), 1778-1781.
20. F. Rousset and M. Raymond, Testing heterozygote excess and deficiency, Genetics 140(4) (1995), 1413-1419.
21. S.C. Keswani et al., Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons, Ann Neurol 54(3) (2003), 287-296. (Pubitemid 37072031)
22. S.B. Oh et al., Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons, J Neurosci 21(14) (2001), 5027-5035. (Pubitemid 32622928)
23. L. Qiu et al., Induction of copper/zinc-superoxide dismutase by CCL5/CCR5 activation causes tumour necrosis factoralpha and reactive oxygen species production in macrophages, Immunology 128(1 Suppl) (2009), e325-e334.
24. J.M. Frade et al., The amino-Terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection, J Clin Invest 100(3) (1997), 497-502. (Pubitemid 27340495)
25. J.W. Homan et al., Inhibition of morphine-potentiated HIV- 1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B), J Acquir Immune Defic Syndr 30(1) (2002), 9-20. (Pubitemid 34506682)
26. L. Gu et al., In vivo properties of monocyte chemoattractant protein-1, J Leukoc Biol 62(5) (1997), 577-580. (Pubitemid 27519767)
27. A. Zhernakova et al., Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes, Genes Immun 7(7) (2006), 544-549. (Pubitemid 44614869)
28. M. Mezger et al., Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells, Blood 111(2) (2008), 534-536.
29. C. Alonso-Villaverde et al., Host-pathogen interactions in the development of metabolic disturbances and atherosclerosis in HIV infection: The role of CCL2 genetic variants, Cytokine 51(3), 251-258.
30. W.S. Modi et al., MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission, AIDS 17(16) (2003), 2357-2365. (Pubitemid 38147022)
31. D.H. McDermott et al., CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study, Circulation 112(8) (2005), 1113-1120. (Pubitemid 41216117)
32. A.R. Kallianpur et al., Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy, AIDS 20(11) (2006), 1503-1513. (Pubitemid 44100211)
33. N. Buchs et al., IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: Interaction with their plasma levels, Genes Immun 2(4) (2001), 222-228. (Pubitemid 33676987)
34. J.K. Yamamoto-Furusho et al., Interleukin 1 beta (IL-1B) and IL-1 Antagonist Receptor (IL-1RN) Gene Polymorphisms are Associated With the Genetic Susceptibility and Steroid Dependence in Patients With Ulcerative Colitis, J Clin Gastroenterol.
35. M. Muller et al., Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: A systematic review and meta-Analysis, Lancet Infect Dis 10(4), 251-261.
36. I. Sereti, A.J. Rodger and M.A. French, Biomarkers in immune reconstitution inflammatory syndrome: Signals from pathogenesis, Curr Opin HIV AIDS 5(6), 504-510.